With the threat of the new Omicon COVID-19 variant, the..
Favilavir is formerly called as Fapilavir
Favilavir is a drug that can counter the novel coronavirus (COVID-19). According to the Taizhou government in Zhejiang province, it was already approved for marketing.
This is the first anti-novel coronavirus drug approved by the National Medical Products Administration for marketing since the outbreak.
As stated by the government on their official WeChat account, the medication is predicted to play a major role in stopping and treating the outbreak, developed by Zhejiang Hisun Pharmaceutical Company.
The Ministry of Science and Technology said, Favilavir was one of three medications that have shown noticeable effectiveness in clinical trials treating the novel coronavirus.
The production of the antiviral drug started on Sunday.